Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

SEPTEMBER 14, 2021

By uniting the strength of Open Book Extract’s quality innovation and custom product development with Radicle Science’s unbiased scientific rigor in natural products research, we can impact every stage of the product life cycle from ideation to validation. About Open Book Extracts. About Radicle Science. Headquartered in Roxboro, N.C.,

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Project CBD

JULY 28, 2023

He has guided clients on license applications, facility design and build out, equipment installation and optimization, and plant oil extraction for cannabis and hemp processing facilities. with unknown pharmacological and safety profiles.”

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. (CSE: TGOD) for cash consideration of C$1.2 HemPoland S.p.a.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

APRIL 29, 2022

The Berlin-based company has a Fast Track Access platform that enables producers worldwide to become part of the German market and focuses on long-term collaborations and carries products such as dried flowers, extracts, Dronabinol and pharmaceutical-grade CBD. Miracle Valley’s operations are based in Mission, B.C.

Pharmaceutical 59

Pharmaceutical Cultivation Extraction Patients 59

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

AUGUST 19, 2021

Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada.

Medicine 98

Medicine Research and Development Therapy Pharmaceutical 98

Cannabis Law Report

FEBRUARY 28, 2022

Here’s an extract of what they say. Further, experts warn that a small number of companies obtaining large swathes of intellectual property in the industry’s nascence could suppress innovation and reduce access to these therapies, thus limiting the great impact that psychedelics have the potential to engender.

Therapy 52

Therapy Pharmaceutical Extraction Access 52

Cannabis Law Report

JULY 11, 2019

We believe that Farmalabor’s extensive experience of the Italian pharmaceutical industry makes it the ideal partner to unlock the full potential of this local market.”. EMMAC is the European medical cannabis company, working to join together the latest science and research with cutting-edge cultivation, extraction and production.

Access 40

Access Supply Chain Research and Development Pharmaceutical 40

Cannabis Law Report

JULY 24, 2021

With full government approval through Health Canada for exclusive access to a full cGMP-certified pharmaceutical manufacturing facility, Mydecine continues to advance the clinical progress in its 4 leading novel compounds, MYCO-001 through 004 with the ability to import or export, cultivate, extract or isolate, and analyze active mushroom compounds.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

The Cannigma

DECEMBER 4, 2022

Patients can be prescribed medical marijuana in the form of pharmaceuticals, like Sativex. In 2019 , a new draft law for medical marijuana was introduced in the Romanian Parliament that would expand the medical program and allow terminally ill patients to access cannabis flower, extracts, resin, and tinctures, with a maximum THC level of 20%.

Law 59

Law Seed-To-Sale Programs Tincture 59

Cannabis Law Report

JULY 22, 2022

The Mildura GMP Licence enables Cann to manufacture Active Pharmaceutical Ingredients (API), hard capsules, Satipharm capsules for human therapeutic use, and perform in-house chemical, physical, and microbiological tests. The GMP approved testing will demonstrate that products meet local and overseas regulatory requirements.

Cultivation 52

Cultivation Medicine Pharmaceutical Extraction 52

Cannabis Law Report

MARCH 17, 2022

Cannabis extracts or strains are from herbal cannabis plants. Cannabis strains are accessible in different formulations. However, sadly, there are not enough restrictions that regulate the manufacturing method of cannabis extracts. The origin of these herbal cannabis extracts concerns a lot! Source Of The CBD Strain.

CBD 52

CBD Extraction Cannabinoids Strains 52

Cannabis Law Report

DECEMBER 15, 2021

“Having a supply partner that gives us access to the rapidly growing U.S. Mycrodose Therapeutics is a US-Based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Miss Marijuana

NOVEMBER 4, 2020

The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. The company has a wide range of products including strain-specific extracted oil, activated THC distillate, and specially-formulated cannabinoid medicine. MPX – Melting Point Extracts. Abx – AbsoluteXrracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Cannabis Law Report

JUNE 24, 2021

and RAD – are well recognized across the country and through GWNG we will benefit from speed-to-market in Quebec and consumers will have access to our high quality, fairly priced products.”. “Products across all of our brands – Pura Vida, Purefarma, Premium 5, feelgood., Follow Heritage’s Purefarma, Pura Vida, Premium 5, and feelgood.

Extraction 95

Extraction Recreational Pharmaceutical Packaging 95

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

MJ Business Attorneys

JUNE 29, 2018

So for now, we wait in anticipation for the DEA to commence proceedings to determine how to amend the scheduling of CBD under the CSA in a way that will allow for Epidiolex to be prescribed by health care providers and dispensed by pharmaceutical companies appropriately and legally.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

MMJ Recs

APRIL 1, 2024

Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

SpeedWeed

AUGUST 9, 2021

It’s an issue around the world: Governments continue to approve expensive, cannabis-based pharmaceutical products for medicinal use, while cultivation of the plant remains illegal for patients (and their families) to grow at home. Thankfully, Peru recently corrected this problem by passing a law in July that expands cannabis patients’ rights.

Law 52

Law Legalization Hydroponic Medicine 52

Veriheal

SEPTEMBER 20, 2021

Now, the latest trend among folks living in states without access to legal cannabis is THC-O. Legalization has helped mitigate some of these issues by increasing access to lab-tested cannabis, which identifies levels of cannabinoids and terpenes as well as dangerous/banned substances. At one time, it was all about THC. Then came CBD.

THC 98

THC Cannabinoids Vaping Hemp 98

Canna Care Docs

SEPTEMBER 18, 2020

Yes, you will be able to upload your records directly to your patient portal which you will receive access to. These oils are extracted by the licensed Pharmaceutical Processors that have been selected to grow, process, and dispense medical cannabis in Virginia. Do I Need to Present my Medical Records to Canna Care Docs?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Canna Law Blog

MARCH 2, 2019

.” Gottleib qualified this by saying that CBD access is not a straightforward issue because CBD has already been investigated and approved as a drug, Epiodiolex , which generally means CBD cannot be added to food. This is where things get interesting.

Hemp 98

Hemp CBD Programs Food 98

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JUNE 19, 2019

Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model. Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, MS 38677, USA. Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR 72223, USA. *. Ewing, L.E.;

CBD 40

CBD Research and Development Extraction Pharmaceutical 40

Canna Care Docs

DECEMBER 11, 2018

Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. Another important aspect for seniors is that medicinal cannabis users tend to take less pharmaceutical drugs. Accessed December 5 2018. Accessed December 5 2018. Let’s take a closer look.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

NOVEMBER 22, 2019

extracts, the number of countries with specific regulations also increases. 11,343/06 (Brazilian Anti-Drug Law) by enabling the commercialization of medicines that contain extracts, substrates or parts of the plant Cannabis sativa in its formulation. 399/15 intends to amend article 2 of Law No. If on the one hand Bill No.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

The Cannigma

JUNE 15, 2021

For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. Another factor that increased CBD’s popularity was the FDA approval of an antiepileptic cannabis-based drug named Epidiolex — a highly concentrated CBD extraction mixed with sesame oil and some flavoring.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

OCTOBER 19, 2019

Company boss Tomaž Frelih told Proactive Investors that it was attracted to the London NEX exchange as a way of accessing growth capital and demonstrating to investors that it is a ‘serious, structured business’. They moved from the Czech Republic to Slovenia where they became recognized as pioneers in pharmaceuticals.

Cultivation 45

Cultivation Hemp Research and Development Pharmaceutical 45

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66

CannaTech

AUGUST 9, 2020

Extensive media coverage and natural health and wellness trends: Growing awareness of CBD’s health benefits, combined with a movement toward natural alternatives to pharmaceuticals, is driving consumer demand for CBD products. Product innovation is also occurring as consumer packaged goods and pharmaceuticals companies enter the CBD market.

CBD 52

CBD Wellness and Beauty Extraction Retail 52

Cannabis Law Report

APRIL 26, 2022

However, cannabis extracts with a concentration of tetrahydrocannabinol (commonly referred to as ‘THC’ and the compound that gives a high) of more than 0.2% will not be allowed. Thailand’s first-move advantage in the Asian cannabis market.

Legislation 52

Legislation Agriculture Research and Development Banking 52

Cannabis Law Report

JULY 11, 2019

Australian medicinal cannabis developer THC Global (ASX: THC) has been granted a second manufacturing licence, this time for its large Southport facility, making it the largest licenced bio-pharma extraction facility in the Southern Hemisphere.

Medicine 40

Medicine THC Research and Development Extraction 40